LONDON - GSK plc (LSE/NYSE: GSK) has announced the acceptance of regulatory filings in China and Japan for depemokimab, a new biologic treatment for asthma with type 2 inflammation and chronic ...
This Community Information message is being issued for areas north of the Grampians National park. . * Smoke from fires and burning out operations in the Grampians National Park is drifting northerly ...
Ian McKnight is researching the biological mechanisms underlying allergies, with the goal of developing new therapeutics to provide long-term relief to fellow allergy sufferers.
At NYU Grossman School of Medicine, our commitment to innovation has led us to bold new ways of bridging the gap between basic science research, medical education, and quality of patient care. With ...
We provide a stimulating and supportive environment where students can thrive. They will become excellent clinicians with a thorough understanding of medicine. We ensure that our students meet the ...